Melissa Hodeib
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 8
- PARP inhibition in cancer therapy 2
-
- Ovarian cancer diagnosis and treatment 8
- Co-authors
- Robert E. Bristow (4 shared papers)Jenny Chang (2 shared papers)Suk‐Joon Chang (1 shared paper)Chun Chao (6 shared papers)Brian S. Mittman (4 shared papers)Quyen Ngo‐Metzger (4 shared papers)Erin E. Hahn (4 shared papers)Lanfang Xu (3 shared papers)
- Journals
- Gynecologic Oncology (8 papers)BioTechniques (1 paper)Implementation Science (1 paper)Future Oncology (1 paper)MMWR Morbidity and Mortality Weekly Report (1 paper)
- Partner nations
- United StatesSouth Korea
In The Last Decade
Melissa Hodeib
24 papers receiving 658 citations
Melissa Hodeib's Hit Papers
Peers
Comparison fields: 5 of 62
- Reproductive Medicine 268
- Obstetrics and Gynecology 78
- Oncology 134
- Surgery 129
- Epidemiology 100
Countries citing papers authored by Melissa Hodeib
This map shows the geographic impact of Melissa Hodeib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Hodeib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Hodeib more than expected).
Fields of papers citing papers by Melissa Hodeib
This network shows the impact of papers produced by Melissa Hodeib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Hodeib. The network helps show where Melissa Hodeib may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa Hodeib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis Hit paper breakdown → | 2013 | 329 |
| 2 | 2021 | 115 | |
| 3 | 2015 | 52 | |
| 4 | 2016 | 48 | |
| 5 | 2013 | 16 | |
| 6 | 2008 | 16 | |
| 7 | 2015 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2007 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2017 | 11 | |
| 12 | 2018 | 7 | |
| 13 | 2020 | 4 | |
| 14 | New paradigms in the surgical and adjuvant treatment of ovarian cancer. | 2014 | 4 |
| 15 | 2018 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2010 | 2 | |
| 18 | 2015 | 2 | |
| 19 | 2016 | 1 | |
| 20 | 2022 | 1 |
About Melissa Hodeib
Melissa Hodeib is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Epidemiology and Surgery, having authored 26 papers that have together received 665 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Cervical Cancer and HPV Research (4 papers), Gene expression and cancer classification (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Advanced Biosensing Techniques and Applications (2 papers), Molecular Biology Techniques and Applications (2 papers), PARP inhibition in cancer therapy (2 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). The work is most often cited by research in Reproductive Medicine (268 citations), Obstetrics and Gynecology (78 citations), Oncology (134 citations), Surgery (129 citations) and Epidemiology (100 citations). Melissa Hodeib has collaborated with scholars based in United States and South Korea. Frequent co-authors include Robert E. Bristow, Jenny Chang, Suk‐Joon Chang, Chun Chao, Brian S. Mittman, Quyen Ngo‐Metzger, Erin E. Hahn, Lanfang Xu, Devansu Tewari and Maureen J. Miller. Their work appears in journals such as Gynecologic Oncology, BioTechniques, Implementation Science, Future Oncology and MMWR Morbidity and Mortality Weekly Report.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.